New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for ...
Contacts: Investors Media Traci McCarty Katherine ...
The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay ...
Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS study PALYNZIQ is the ...
Some research suggests that avoiding environmental exposures, especially pre-conception, may help. Influencers branded the ...
In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare diseases, many of which are genetic […] ...
The free package, valued at 4,286 yuan ($622.7), includes genetic screening before pregnancy, prenatal testing, newborn ...
Mandatory testing of 45 genetic disorders is designed to lead to treatment before symptoms do damage.
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of "Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges" in ...
February 25, 2026 marks one year since KJ, an infant born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, became the world's first person to receive a personalized CRISPR-based gene ...
Brayton Purcell LLP announced today that the firm has secured almost $200 million in verdicts and settlements on behalf of countertop fabrication workers diagnosed with accelerated silicosis caused by ...
The FDA expands Palynziq approval to include pediatric patients aged 12 years and older with phenylketonuria and uncontrolled blood Phe levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results